|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Association of k-ras, b-raf,and p53 status with the treatment effect of bevacizumab 显示文摘 | Ince WL Jubb AM Holden SN | 2005 | J NatlCancer Inst2005，97，13： | 1 |
| 2 | Assessment of tumor hypoxia for prediction of response to therapy and cancer prognosis 显示文摘 | Jubb AM Buffa FM Harris AL | 2010 | J Cell Mol Med2010，14，112： | 1 |
| 3 | Expression of vascular Notch li- gands Delta-liked and Jagged-1 in glioblastoma显示文摘 | Jubb AM Browning L Campo L | 2012 | Histopathology2012，60，5： | 1 |
| 4 | Assessment of tumor hypoxia for prediction of response to therapy and cancer prognosis显示文摘 | JUBB AM BUFFA FM HARRIS AL | 2010 | J Cell Mol Med2010，14，12： | 1 |
| 5 | p21-activated kinase 1: PAK'ed with potential显示文摘 | Ong CC Jubb AM Zhou W | 2011 | Oncotarget2011，2，6： | 1 |
| 6 | Methylation and colorectal cancer显示文摘 | Jubb AM Bell SM Quirke P | 2001 | J Pathol2001，195，1： | 1 |
| 7 | Biomarkers to predict the clinical efficacy of bevacizumab in cancer显示文摘 | Jubb AM Harris AL | 2010 | Lancet Oncol2010，11，12： | 1 |
| 8 | The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia,and is a key mediator of estrogen induced growth显示文摘 | YangJ Jubb AM Pike L | | 0，，： | 1 |
| 9 | Predictive impact of circu?lating cascular endothelial growth factor in four phase III trials e?valuating bevacizumab显示文摘 | Hegde PS Jubb AM Chen D | 2014 | Clin Cancer Res2014，19，4： | 1 |
| 10 | Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells显示文摘 | Ong CC Jubb AM Haverty PM | 2011 | Proc Natl Acad Sci U S A2011，108，17： | 1 |
| 11 | Predicting benefits from anti-angiogenic agents in malignancy显示文摘 | Jubb AM Oates AJ Holden S | 2006 | Nature Rev Cancer2006，6，8： | 1 |
| 12 | p21-activated kinase 1:PAK' ed with potential显示文摘 | Ong CC Jubb AM Zhou W | | 0，，6： | 1 |
| 13 | Expression of vascular endothelial growth faetor,hypoxia inducible factor lalpha, and carbonic anhydrase IX in human tumours 显示文摘 | Jubb AM Pham TQ Hanby AM | 2004 | J Clin Pathol2004，57，： | 1 |
| 14 | Impact of vascular endothelial growth factor-A expression,thrombospondin-2 expression,and microvessel density on the treatment effeet of bevacizumab in metastatic colorectal cancer显示文摘 | Jubb AM Hurwitz HI Bai W | 2006 | J Clin Oncol2006，24，2： | 1 |
| 15 | P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma 显示文摘 | Ong CC Jubb AM Jakubiak D | 2013 | J Natl Cancer Inst2013，105，9： | 1 |
| 16 | Impact of vascular endothelial growth factor:a expression,thrombospondin-2 expression,and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer显示文摘 | Jubb AM Hurwitz HI | 2006 | J Clin Oncol2006，24，2： | 1 |
| 17 | Achaete-scute like 2 (ascl2) is a target of Wnt signaling and upregulated in intestinal neoplasia显示文摘 | Jubb AM Chalasani S Frantz GD | 2006 | Oncogene2006，25，24： | 1 |
| 18 | Biomarkers to predict the clinical efficacy ofbe- vacizumab in cancer显示文摘 | Jubb AM Harris AL | 2010 | Lancet Oncol2010，11，12： | 1 |
| 19 | Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer 显示文摘 | Jubb AM Hurwitz HI Bai W | 2006 | J Clin Oncol2006，24，2： | 1 |
| 20 | The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth显示文摘 | Yang J Jubb AM Pike L | 2010 | Cancer Res2010，70，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员